CATALYST PHARMACEUTICALS, INC. — Director's Dealing 2012

Dec 14, 2012

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: CATALYST PHARMACEUTICAL PARTNERS, INC. (CPRX)
CIK: 0001369568
Period of Report: 2012-12-12

Reporting Person: Tierney David S (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2012-12-12	Options to purchase common stock	$0.47	A	50000	Acquired	2017-12-12	Common Stock (50000)	Direct